nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
After the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study: Implications for Fenofibrate
|
Sacks, Frank M. |
|
2008 |
102 |
12S |
p. 34L-40L nvt p. |
artikel |
2 |
A Review of the Current Status of the Management of Mixed Dyslipidemia Associated with Diabetes Mellitus and Metabolic Syndrome
|
Davidson, Michael |
|
2008 |
102 |
12S |
p. 19L-27L nvt p. |
artikel |
3 |
Expert Perspective: Reducing Cardiovascular Risk in Metabolic Syndrome and Type 2 Diabetes Mellitus Beyond Low-Density Lipoprotein Cholesterol Lowering
|
Jones, Peter H. |
|
2008 |
102 |
12S |
p. 41L-47L nvt p. |
artikel |
4 |
Faculty Disclosures
|
|
|
2008 |
102 |
12S |
p. v- 1 p. |
artikel |
5 |
Faculty List
|
|
|
2008 |
102 |
12S |
p. iv- 1 p. |
artikel |
6 |
Fenofibrate for Cardiovascular Disease Prevention in Metabolic Syndrome and Type 2 Diabetes Mellitus
|
Steiner, George |
|
2008 |
102 |
12S |
p. 28L-33L nvt p. |
artikel |
7 |
Introduction
|
Sacks, Frank M. |
|
2008 |
102 |
12S |
p. 1L-4L nvt p. |
artikel |
8 |
Microvascular Complications of Diabetes Mellitus: Renal Protection Accompanies Cardiovascular Protection
|
Brown, W. Virgil |
|
2008 |
102 |
12S |
p. 10L-13L nvt p. |
artikel |
9 |
Mixed Dyslipidemia, Metabolic Syndrome, Diabetes Mellitus, and Cardiovascular Disease: Clinical Implications
|
Cannon, Christopher P. |
|
2008 |
102 |
12S |
p. 5L-9L nvt p. |
artikel |
10 |
Nonpharmacologic Management of Mixed Dyslipidemia Associated with Diabetes Mellitus and the Metabolic Syndrome: A Review of the Evidence
|
Stone, Neil J. |
|
2008 |
102 |
12S |
p. 14L-18L nvt p. |
artikel |
11 |
Title page
|
|
|
2008 |
102 |
12S |
p. i- 1 p. |
artikel |